Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

In recent years, neoadjuvant treatment trials have shown that breast cancer subtypes identified on the basis of genomic and/or molecular signatures exhibit different response rates and recurrence outcomes, with the implication that subtype-specific treatment approaches are needed. Estrogen receptor-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Ella F., Hathi, Deep K., Freimanis, Rita, Mukhtar, Rita A., Chien, A. Jo, Esserman, Laura J., van’t Veer, Laura J., Joe, Bonnie N., Hylton, Nola M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352259/
https://www.ncbi.nlm.nih.gov/pubmed/32527022
http://dx.doi.org/10.3390/cancers12061511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352259/
https://www.ncbi.nlm.nih.gov/pubmed/32527022
http://dx.doi.org/10.3390/cancers12061511

Ejemplares similares